Cargando…

2457. Improved Identification of Primary Infection Sites in Suspect Central Line Bloodstream Infections (CLABSI) through Preliminary Blood Culture Notifications

BACKGROUND: Central Line Bloodstream Infections (CLABSI) pose a significant risk for patients with high burden of morbidity and mortality. Accurate and timely identification of these events is paramount for the development of effective interventions. METHODS: A quasi-experimental (before/after) stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bischoff, Werner, Kieta, Cheryl, LaFontaine, Tiffany, Billings, Corrianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679370/ http://dx.doi.org/10.1093/ofid/ofad500.2075

Ejemplares similares

To Be a CLABSI or Not to Be a CLABSI—That Is the Question: The Epidemiology of Bloodstream Infections in a Large ECMO Population
por: Seidelman, Jessica, et al.
Publicado: (2017)

APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI)
por: Ling, Moi Lin, et al.
Publicado: (2016)

113. Accuracy of the NHSN Central Line-Associated Bloodstream Infection (CLABSI) Definition
por: Hammadi, Ahmed Al, et al.
Publicado: (2018)

Central-line associated bloodstream infection (CLABSI) in patients hospitalized with COVID-19
por: Kang, Minji, et al.
Publicado: (2022)

The evaluation of central-line–associated bloodstream infection (CLABSI) preventability at an academic institution
por: Hsueh, Leon, et al.
Publicado: (2022)

1286 Blood Product Transfusions and the Risk of Central Line-Associated Bloodstream Infections (CLABSI)
por: Hake, Kristin, et al.
Publicado: (2014)

Reducing Central Line Associated Bloodstream Infections (CLABSIs) by Reducing Central Line Days
por: Beville, Amber Shaye McElveen, et al.
Publicado: (2021)

Prevalence of Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care and Medical-Surgical Units
por: Toor, Harjyot, et al.
Publicado: (2022)

Controlling the chaos: Information management in home-infusion central-line–associated bloodstream infection (CLABSI) surveillance
por: Hannum, Susan M., et al.
Publicado: (2023)

Reducing Central-Line–Associated Bloodstream Infections (CLABSI): An Improvement Project in a Specialized Tertiary Hospital
por: Mostafa, Fadwa Abu, et al.
Publicado: (2022)

2110. Taurolidine-Citrate Lock Solution for the Prevention of Central-Line-associated Bloodstream Infection (CLABSI) in Pediatric Hematology-Oncology and Gastrointestinal Failure Patients with High Baseline CLABSI Rates
por: Chong, Chia Yin, et al.
Publicado: (2018)

Four year surveillance of central line-associated bloodstream infection (CLABSI) in neonatal intensive care unit (NICU)
por: Décary, A, et al.
Publicado: (2011)

Poor adherence to guidelines for preventing central line-associated bloodstream infections (CLABSI): results of a worldwide survey
por: Valencia, Cristina, et al.
Publicado: (2016)

A multifaceted approach in reducing central line associated bloodstream infections (CLABSI) in pediatric icus at a tertiary hospital
por: Balkhy, H, et al.
Publicado: (2015)

777. Implementation of Antimicrobial Impregnated Catheters to Reduce Central Line Associated Bloodstream Infections (CLABSI) in a Pediatric Setting
por: Patel, Ami B, et al.
Publicado: (2021)

Central-line–associated bloodstream infections and central-line–associated non-CLABSI complications among pediatric oncology patients
por: Kelada, Aml S., et al.
Publicado: (2023)

Coronavirus disease 2019 (COVID-19) impact on central-line-associated bloodstream infections (CLABSI): a systematic review
por: Satta, Giovanni, et al.
Publicado: (2023)

Blood Culture Result Profile in Patients With Central Line-Associated Bloodstream Infection (CLABSI): A Single-Center Experience
por: Akaishi, Tetsuya, et al.
Publicado: (2023)

1668. The SAFER Lines Project: A Mobile-App Strategy for Prevention of Outpatient Central Line Associated Bloodstream Infection (CLABSI)
por: Gohil, Shruti K, et al.
Publicado: (2022)

Surveillance of central line associated bloodstream infection (CLABSI) – comparison of current (CDC/NHSN) and modified criteria: A prospective study
por: Rai, Durgesh, et al.
Publicado: (2023)

Characterizing the relationship between coronavirus disease 2019 (COVID-19) and central-line–associated bloodstream infection (CLABSI) and assessing the impact of a nursing-focused CLABSI reduction intervention during the COVID-19 pandemic
por: Ben-Aderet, Michael A., et al.
Publicado: (2023)

The Clasp of CLABSI
por: Gopal, Palepu B
Publicado: (2020)

2435. Stewardship – It’s Not Just Antibiotics and Testing
por: Sampson, Mindy, et al.
Publicado: (2023)

A survey of Preventive Measures Used and their Impact on Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care Units (SPIN-BACC)
por: Gonzales, Milagros, et al.
Publicado: (2013)

Identifying Structural Factors Associated with Central Line-Associated Bloodstream Infections (CLABSI) Risk in a Single-Center Pediatric Academic Hospital
por: Monsees, Elizabeth, et al.
Publicado: (2017)

775. Risk Factors for Healthcare Associated Central Line-Associated Bloodstream Infection (CLABSI) to Identify Novel Infection Prevention Areas - A Case-Control Study
por: Oo, Aung Myat, et al.
Publicado: (2021)

713. Vancomycin Heteroresistance in Coagulase Negative Staphylococci (CoNS) Causing Central Line-Associated Bloodstream Infection (CLABSI) in Pediatric Patients with Leukemia
por: Dao, Tina, et al.
Publicado: (2018)

Clinical value of procalcitonin for suspected nosocomial bloodstream infection
por: Cha, Joo Kyoung, et al.
Publicado: (2018)

Risk Factors of Central Line-Associated Bloodstream Infection (CLABSI): A Prospective Study From a Paediatric Intensive Care Unit in South India
por: Sellamuthu, Ravina, et al.
Publicado: (2023)

856 Hospital Acquired Staphylococcus aureus Primary Blood Stream Infection: A Comparison of Events That Do and Do Not Meet Central Line Associated Bloodstream Infection (CLABSI) Definition
por: Kovacs, Christopher, et al.
Publicado: (2014)

2016. CLABSIs in the Time of COVID
por: Espiritu, Maria Rosa Velasquez, et al.
Publicado: (2022)

A Recipe for Success: Conducting a Gap Analysis to Decrease Central Line-associated Bloodstream Infection (CLABSI) Rates in a Post-COVID-19 World
por: Delano, John P., et al.
Publicado: (2022)

2433. Implementation of Midline Vascular Access Program and Reduction of Central Line-Associated Bloodstream Infections (CLABSI) in an Intensive Care Unit at a Community-Based Hospital
por: SAAD, E L T A I B A, et al.
Publicado: (2023)

1,8-Dihydroxy-2,4,5,7-tetranitro-9,10-anthraquinone
por: Armaghan, Mahsa, et al.
Publicado: (2010)

2457. Multivariate Analyses of Socio-Economic Inequities in Parental Awareness and Utilization of Meningococcal Serogroup B Vaccines
por: Huang, Liping, et al.
Publicado: (2018)

Rapid, Paralog-Sensitive CNV Analysis of 2457 Human Genomes Using QuicK-mer2
por: Shen, Feichen, et al.
Publicado: (2020)

776. Reducing Central Line Associated Bloodstream Infections (CLABSI) in a High-Risk Cohort of Patients by Standardizing Skin Preparation Prior to Pulmonary Artery Catheter Insertion
por: Yun, Mylinh, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) pandemic, central-line–associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts
por: Fakih, Mohamad G., et al.
Publicado: (2021)

Clinical Diagnostic Performance of Droplet Digital PCR for Suspected Bloodstream Infections
por: Lin, Ke, et al.
Publicado: (2023)

PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE
por: José Jiménez Nájar, Francisco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p6qkh7phe3m6mcd7jtiee2o8fd